BioTech
BSX

Boston Scientific swings to loss as medical device sales sink

Medical device maker Boston Scientific Corp reported a second-quarter loss on Wednesday, hurt by lower demand for specialty medical devices as patients continued to defer elective procedures during the COVID-19 pandemic.

July 29 (Reuters) - Medical device maker Boston Scientific Corp BSX.N reported a second-quarter loss on Wednesday, hurt by lower demand for specialty medical devices as patients continued to defer elective procedures during the COVID-19 pandemic.

Net loss attributable to Boston Scientific was $153 million, or 11 cents per share, in the quarter ended June 30, compared with net earnings of $154 million, or 11 cents per share, last year.

Sales fell to $2.00 billion from $2.63 billion.

(Reporting by Trisha Roy and Mrinalika Roy in Bengaluru; Editing by Devika Syamnath)

((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6182 3635;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BSX

Other Topics

US Markets

Latest BioTech Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More